首页> 外文期刊>Life sciences >Luteolin suppresses inflammation-associated gene expression by blocking NF-kappa B and AP-1 activation pathway in mouse alveolar macrophages
【24h】

Luteolin suppresses inflammation-associated gene expression by blocking NF-kappa B and AP-1 activation pathway in mouse alveolar macrophages

机译:木犀草素通过阻断小鼠肺泡巨噬细胞中的NF-κB和AP-1激活途径来抑制炎症相关基因的表达

获取原文
获取原文并翻译 | 示例
           

摘要

Luteolin. a plant flavonoid, has potent anti-inflammatory proper-ties both in vitro and in vivo. However, the molecular mechanism of luteolin-mediated immune modulation has not been fully understood. In this study, we examined the effects of luteolin on the production of nitric oxide (NO) and prostaglandin E-2 (PGE(2)), as well as the expression of inducible NO synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) in mouse alveolar macrophage MH-S and peripheral macrophage RAW 264.7 cells. Luteolin dose-dependently inhibited the expression and production of these inflammatory genes and mediators in macrophages stimulated with lipopolysaccharide (LPS). Semi-quantitative reverse-transcription polymerase chain reaction (RT-PCR) assay further confirmed the suppression of LPS-induced TNF- alpha, IL-6, iNOS and COX-2 gene expression by luteolin at a transcriptional level. Luteolin also reduced the DNA binding activity of nuclear factor-kappa B (NF-kappa B) in LPS-activated macrophages. Moreover, luteolin blocked the degradation of I kappa B-alpha and nuclear translocation of NF-kappa B p65 subunit. In addition, luteolin significantly inhibited the LPS-induced DNA binding activity of activating protein-1 (AP-1). We also found that luteolin attenuated the LPS-mediated protein kinase B (Akt) and IKK phosphorylation, as well as reactive oxygen species (ROS) production. In sum, these data suggest that, by blocking NF-kappa B and AP-1 activation, luteolin acts to suppress the LPS-elicited inflammatory events in mouse alveolar macrophages, and this effect was mediated, at least in part, by inhibiting the generation of reactive oxygen species. Our observations suggest a possible therapeutic application of this agent for treating inflammatory disorders in lung. (C) 2007 Elsevier Inc. All rights reserved.
机译:木犀草素。一种植物类黄酮,在体外和体内均具有有效的抗炎特性。然而,木犀草素介导的免疫调节的分子机制尚未完全了解。在这项研究中,我们研究了木犀草素对一氧化氮(NO)和前列腺素E-2(PGE(2))的产生以及诱导型一氧化氮合酶(iNOS),环氧合酶2(COX- 2),小鼠肺泡巨噬细胞MH-S和外周巨噬细胞RAW 264.7细胞中的肿瘤坏死因子-α(TNF-α)和白介素6(IL-6)。木犀草素剂量依赖性地抑制脂多糖(LPS)刺激的巨噬细胞中这些炎症基因和介质的表达和产生。半定量逆转录聚合酶链反应(RT-PCR)分析进一步证实了木犀草素在转录水平上抑制LPS诱导的TNF-α,IL-6,iNOS和COX-2基因表达。木犀草素还降低了LPS激活的巨噬细胞中核因子-κB(NF-κB)的DNA结合活性。此外,木犀草素阻断了IκB-α的降解和NF-κBp65亚基的核易位。此外,木犀草素显着抑制LPS诱导的活化蛋白1(AP-1)的DNA结合活性。我们还发现木犀草素减弱了LPS介导的蛋白激酶B(Akt)和IKK磷酸化以及活性氧(ROS)的产生。总之,这些数据表明,木犀草素通过阻断NF-κB和AP-1的活化,抑制小鼠肺泡巨噬细胞中LPS引起的炎症事件,并且至少部分地通过抑制这种生成来介导这种作用。活性氧种类我们的观察结果表明该药物可能用于治疗肺部炎症。 (C)2007 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号